Citius Pharma (CTXR) Video Presentation.

Chairman Leonard Mazur Discusses: Mino-Lok Treatment for Infected Catheters. Novellus Stem Cell Treatment...

Mitesco Inc. Initiates “The Good Clinic” Rollout in Minneapolis; Introduces the Founders of “The...

MINNEAPOLIS, MN, Sept. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Mitesco, Inc. (OTCQB: MITI) today announced that The Good Clinic, LLC has filed...
aPHEX bIOcLEANSE

Hy-IQ Trademark

REGISTERED 9-15-2020

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...

Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.

Interesting Charts From the Day we Discovered it. Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced...
American BriVision

American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.

Is Wall Street Missing American Brivision's Full Clinical Safety and Efficacy Study? We Think it has. Potential...

There’s Simply No Loyalty Anymore.

TODAY'S LETTER Frontier Bio (FBIO) $3.90. We Have Another Double! American BriVision (ABVC) $4.00. Wait, What? Yet...
Aphex BioCleanse

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Aphex BioCleanse Systems Enters Agreement with Now Biopharma for Hand Sanitizer Clinical Trial PITTSFORD, N.Y., Aug. 31, 2020 /PRNewswire/ -- Aphex...

American BriVision’s (ABVC) Novel Polygala Plant Extract, for the Treatment of Clinical Depression.

American BriVision Announces New Patent Filed for Treatment of Major Depressive Disorder. Phase II clinical study completed at...

Photos: Aphex BioCleanse Systems.

We had the opportunity to visit the Aphex BioCleanse Systems manufacturing facility on 8-18-2020. Truly impressive seeing tanks readying for shipment, and...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!